Internal Nanobodies Tackle Cystic Fibrosis
Researchers have developed a novel method to deliver nanobodies, which are small antibody fragments, directly inside cells to treat cystic fibrosis. These nanobodies are fused with a cell-penetrating peptide, enabling them to cross the cell membrane and stabilize the misfolded CFTR protein from within. When combined with existing therapies, this approach has shown potential to restore nearly normal protein function in patient-derived cells. AI
IMPACT Novel delivery mechanism for protein therapeutics could accelerate development of intracellular treatments for various diseases.